FR2046920B1
(ru)
|
1969-06-19 |
1974-05-03 |
Citizen Watch Co Ltd |
|
US3940475A
(en)
|
1970-06-11 |
1976-02-24 |
Biological Developments, Inc. |
Radioimmune method of assaying quantitatively for a hapten
|
US4588585A
(en)
|
1982-10-19 |
1986-05-13 |
Cetus Corporation |
Human recombinant cysteine depleted interferon-β muteins
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
AU4434585A
(en)
|
1985-03-30 |
1986-10-23 |
Marc Ballivet |
Method for obtaining dna, rna, peptides, polypeptides or proteins by means of a dna recombinant technique
|
US4737456A
(en)
|
1985-05-09 |
1988-04-12 |
Syntex (U.S.A.) Inc. |
Reducing interference in ligand-receptor binding assays
|
US4676980A
(en)
|
1985-09-23 |
1987-06-30 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Target specific cross-linked heteroantibodies
|
US5618920A
(en)
|
1985-11-01 |
1997-04-08 |
Xoma Corporation |
Modular assembly of antibody genes, antibodies prepared thereby and use
|
DE3600905A1
(de)
|
1986-01-15 |
1987-07-16 |
Ant Nachrichtentech |
Verfahren zum dekodieren von binaersignalen sowie viterbi-dekoder und anwendungen
|
US5681718A
(en)
|
1986-03-14 |
1997-10-28 |
Celltech Limited |
Methods for enhanced production of tissue plasminogen activator in cell culture using alkanoic acids or salts thereof
|
US5225539A
(en)
|
1986-03-27 |
1993-07-06 |
Medical Research Council |
Recombinant altered antibodies and methods of making altered antibodies
|
US4946778A
(en)
|
1987-09-21 |
1990-08-07 |
Genex Corporation |
Single polypeptide chain binding molecules
|
US5763192A
(en)
|
1986-11-20 |
1998-06-09 |
Ixsys, Incorporated |
Process for obtaining DNA, RNA, peptides, polypeptides, or protein, by recombinant DNA technique
|
JP3040121B2
(ja)
|
1988-01-12 |
2000-05-08 |
ジェネンテク,インコーポレイテッド |
増殖因子レセプターの機能を阻害することにより腫瘍細胞を処置する方法
|
GB8823869D0
(en)
|
1988-10-12 |
1988-11-16 |
Medical Res Council |
Production of antibodies
|
GB8826530D0
(en)
|
1988-11-12 |
1988-12-14 |
Ped Capacitors Ltd |
Electrical capacitors
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
US20040049014A1
(en)
|
1988-12-28 |
2004-03-11 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
US5108921A
(en)
|
1989-04-03 |
1992-04-28 |
Purdue Research Foundation |
Method for enhanced transmembrane transport of exogenous molecules
|
CA2016841C
(en)
|
1989-05-16 |
1999-09-21 |
William D. Huse |
A method for producing polymers having a preselected activity
|
AU652539B2
(en)
|
1989-05-16 |
1994-09-01 |
Medical Research Council |
Co-expression of heteromeric receptors
|
CA2016842A1
(en)
|
1989-05-16 |
1990-11-16 |
Richard A. Lerner |
Method for tapping the immunological repertoire
|
JP3068180B2
(ja)
|
1990-01-12 |
2000-07-24 |
アブジェニックス インコーポレイテッド |
異種抗体の生成
|
US6916605B1
(en)
|
1990-07-10 |
2005-07-12 |
Medical Research Council |
Methods for producing members of specific binding pairs
|
GB9015198D0
(en)
|
1990-07-10 |
1990-08-29 |
Brien Caroline J O |
Binding substance
|
US6172197B1
(en)
|
1991-07-10 |
2001-01-09 |
Medical Research Council |
Methods for producing members of specific binding pairs
|
JP3306063B2
(ja)
|
1990-08-24 |
2002-07-24 |
イグジス, インコーポレイテッド |
ランダムコドンを有するオリゴヌクレオチドを合成する方法
|
US5661016A
(en)
|
1990-08-29 |
1997-08-26 |
Genpharm International Inc. |
Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
|
ATE158021T1
(de)
|
1990-08-29 |
1997-09-15 |
Genpharm Int |
Produktion und nützung nicht-menschliche transgentiere zur produktion heterologe antikörper
|
US5545806A
(en)
|
1990-08-29 |
1996-08-13 |
Genpharm International, Inc. |
Ransgenic non-human animals for producing heterologous antibodies
|
US5625126A
(en)
|
1990-08-29 |
1997-04-29 |
Genpharm International, Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
US5633425A
(en)
|
1990-08-29 |
1997-05-27 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
ATE164395T1
(de)
|
1990-12-03 |
1998-04-15 |
Genentech Inc |
Verfahren zur anreicherung von proteinvarianten mit geänderten bindungseigenschaften
|
IL100460A
(en)
|
1990-12-20 |
1997-06-10 |
Ixsys |
Method for optimization of binding proteins and nucleic acids encoding a binding protein produced thereby
|
DE69229477T2
(de)
|
1991-09-23 |
1999-12-09 |
Cambridge Antibody Tech |
Methoden zur Herstellung humanisierter Antikörper
|
US5885793A
(en)
|
1991-12-02 |
1999-03-23 |
Medical Research Council |
Production of anti-self antibodies from antibody segment repertoires and displayed on phage
|
ES2202310T3
(es)
|
1991-12-13 |
2004-04-01 |
Xoma Corporation |
Metodos y materiales para la preparacion de dominios variables de anticuerpos modificados y sus usos terapeuticos.
|
US5965132A
(en)
|
1992-03-05 |
1999-10-12 |
Board Of Regents, The University Of Texas System |
Methods and compositions for targeting the vasculature of solid tumors
|
DK0627940T3
(da)
|
1992-03-05 |
2003-09-01 |
Univ Texas |
Anvendelse af immunokonjugater til diagnose og/eller terapi af vaskulariserede tumorer
|
US20030148406A1
(en)
|
1992-03-17 |
2003-08-07 |
David John King |
Multivalent antigen-binding proteins
|
US5639641A
(en)
|
1992-09-09 |
1997-06-17 |
Immunogen Inc. |
Resurfacing of rodent antibodies
|
AU6132994A
(en)
|
1993-02-02 |
1994-08-29 |
Scripps Research Institute, The |
Methods for producing antibody libraries using universal or randomized immunoglobulin light chains
|
EP0714409A1
(en)
|
1993-06-16 |
1996-06-05 |
Celltech Therapeutics Limited |
Antibodies
|
US5731168A
(en)
|
1995-03-01 |
1998-03-24 |
Genentech, Inc. |
Method for making heteromultimeric polypeptides
|
US5641870A
(en)
|
1995-04-20 |
1997-06-24 |
Genentech, Inc. |
Low pH hydrophobic interaction chromatography for antibody purification
|
CA2761116A1
(en)
|
1995-04-27 |
1996-10-31 |
Amgen Fremont Inc. |
Human antibodies derived from immunized xenomice
|
CA2219486A1
(en)
|
1995-04-28 |
1996-10-31 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
US6828422B1
(en)
|
1995-08-18 |
2004-12-07 |
Morphosys Ag |
Protein/(poly)peptide libraries
|
JP4436457B2
(ja)
|
1995-08-18 |
2010-03-24 |
モルフォシス アイピー ゲーエムベーハー |
蛋白質/(ポリ)ペプチドライブラリー
|
WO1997011971A1
(en)
|
1995-09-28 |
1997-04-03 |
Alexion Pharmaceuticals, Inc. |
Porcine cell interaction proteins
|
US6331431B1
(en)
|
1995-11-28 |
2001-12-18 |
Ixsys, Inc. |
Vacuum device and method for isolating periplasmic fraction from cells
|
US5714352A
(en)
|
1996-03-20 |
1998-02-03 |
Xenotech Incorporated |
Directed switch-mediated DNA recombination
|
KR20080059467A
(ko)
|
1996-12-03 |
2008-06-27 |
아브게닉스, 인크. |
복수의 vh 및 vk 부위를 함유하는 사람 면역글로불린유전자좌를 갖는 형질전환된 포유류 및 이로부터 생성된항체
|
US6596850B1
(en)
|
1998-01-30 |
2003-07-22 |
Ixsys, Incorporated |
Anti-αv3β3 recombinant human antibodies, nucleic acids encoding same
|
EP1007967A2
(en)
|
1997-08-04 |
2000-06-14 |
Ixsys, Incorporated |
Methods for identifying ligand specific binding molecules
|
CA2354862A1
(en)
|
1998-10-19 |
2000-04-27 |
Yeda Research And Development Co. Ltd. |
Treatment of systemic lupus erythematosus by down-regulating the autoimmune response to autoantigens
|
US20040031072A1
(en)
|
1999-05-06 |
2004-02-12 |
La Rosa Thomas J. |
Soy nucleic acid molecules and other molecules associated with transcription plants and uses thereof for plant improvement
|
WO2001002588A2
(en)
|
1999-07-02 |
2001-01-11 |
Morphosys Ag |
Generation of specific binding partners binding to (poly)peptides encoded by genomic dna fragments or ests
|
IT1307309B1
(it)
|
1999-12-30 |
2001-10-30 |
Enea Ente Nuove Tec |
Peptidi stabilizzanti, polipeptidi ed anticorpi che li comprendono.
|
NZ521898A
(en)
|
2000-03-31 |
2004-11-26 |
Purdue Research Foundation |
Use of a ligand-immunogen conjugate such as folate-FITC for enhancing an endogenous immune response
|
DE10037759A1
(de)
|
2000-08-03 |
2002-07-04 |
Gruenenthal Gmbh |
Screeningverfahren
|
ATE400030T1
(de)
|
2001-02-19 |
2008-07-15 |
Merck Patent Gmbh |
Methode zur identifizierung von t-zellepitopen und deren anwendung zur herstellung von molekülen mit reduzierter immunogenität
|
AU2002258518A1
(en)
|
2001-03-14 |
2002-09-24 |
Millennium Pharmaceuticals, Inc. |
Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancer
|
WO2002087424A2
(en)
|
2001-05-02 |
2002-11-07 |
Purdue Research Foundation |
Treatment and diagnosis of macrophage mediated disease
|
US7314974B2
(en)
|
2002-02-21 |
2008-01-01 |
Monsanto Technology, Llc |
Expression of microbial proteins in plants for production of plants with improved properties
|
WO2003074704A1
(fr)
|
2002-03-01 |
2003-09-12 |
Japan Envirochemicals, Ltd. |
Proteines capables de se lier aux hormones sexuelles feminines et procede de preparation
|
CA2482607C
(en)
|
2002-04-22 |
2013-06-11 |
Fraunhofer-Gesellschaft Zur Foerderung Der Angewandten Forschung E.V. |
Antibodies, recombinant antibodies, recombinant antibody fragments and fusions mediated plant disease resistance against fungi
|
US7538195B2
(en)
|
2002-06-14 |
2009-05-26 |
Immunogen Inc. |
Anti-IGF-I receptor antibody
|
GB0216648D0
(en)
|
2002-07-18 |
2002-08-28 |
Lonza Biologics Plc |
Method of expressing recombinant protein in CHO cells
|
HUE026914T2
(en)
|
2002-11-07 |
2016-08-29 |
Immunogen Inc |
Anti-CD33 antibodies and a method of treating acute myeloid leukemia
|
AU2003295411A1
(en)
|
2002-11-07 |
2004-06-03 |
Celltech R & D |
Human monoclonal antibodies to heparanase
|
EP1481993A1
(en)
|
2003-05-28 |
2004-12-01 |
Xerion Pharmaceuticals AG |
Modulation of the poliovirus receptor function
|
US20050255114A1
(en)
|
2003-04-07 |
2005-11-17 |
Nuvelo, Inc. |
Methods and diagnosis for the treatment of preeclampsia
|
US20050025763A1
(en)
|
2003-05-08 |
2005-02-03 |
Protein Design Laboratories, Inc. |
Therapeutic use of anti-CS1 antibodies
|
CA2897608C
(en)
|
2003-05-09 |
2018-07-31 |
Duke University |
Cd20-specific antibodies and methods employing same
|
KR101424624B1
(ko)
|
2003-05-14 |
2014-07-31 |
이뮤노젠 아이엔씨 |
약물 콘쥬게이트 조성물
|
US7276497B2
(en)
|
2003-05-20 |
2007-10-02 |
Immunogen Inc. |
Cytotoxic agents comprising new maytansinoids
|
AU2004253953A1
(en)
|
2003-07-02 |
2005-01-13 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of tumor
|
US7622112B2
(en)
|
2003-12-05 |
2009-11-24 |
Jody Berry |
Anti-SARS monoclonal antibodies
|
EP3101034A1
(en)
|
2004-02-12 |
2016-12-07 |
Morphotek, Inc. |
Monoclonal antibodies that specifically bind to folate receptor alpha
|
WO2005075514A2
(en)
|
2004-03-10 |
2005-08-18 |
Lonza Ltd. |
Method for producing antibodies
|
EP2259063B1
(en)
|
2004-04-27 |
2012-05-23 |
Galapagos N.V. |
Compound screening assays for inducing differentiation of undifferentiated mammalian cells into osteoblasts
|
CA2581208A1
(en)
|
2004-08-30 |
2006-03-09 |
Lonza Biologics Plc. |
Affinity- plus ion exchange- chromatography for purifying antibodies
|
US7776869B2
(en)
|
2004-10-18 |
2010-08-17 |
Amgen Inc. |
Heteroaryl-substituted alkyne compounds and method of use
|
AU2005306997B2
(en)
|
2004-10-25 |
2012-07-05 |
Merck Sharp & Dohme Corp. |
Anti-ADDL antibodies and uses thereof
|
CA2595171C
(en)
|
2004-12-21 |
2015-03-17 |
Monsanto Technology Llc |
Transgenic plants with enhanced agronomic traits
|
BRPI0518994A2
(pt)
|
2004-12-31 |
2008-12-02 |
Biogen Idec Inc |
anticorpos ou polipeptÍdeos que se ligam a br3, seus usos e formulaÇÕes lÍquidas
|
EP2153848A3
(en)
|
2005-01-27 |
2010-07-21 |
The Regents of the University of California |
Therapeutic monoclonal antibodies that neutralize botulinium neurotoxins
|
US7608413B1
(en)
|
2005-03-25 |
2009-10-27 |
Celera Corporation |
Kidney disease targets and uses thereof
|
DK1866339T3
(da)
|
2005-03-25 |
2013-09-02 |
Gitr Inc |
GTR-bindende molekyler og anvendelser heraf
|
CA2602585A1
(en)
|
2005-03-30 |
2006-10-05 |
Purdue Research Foundation |
Method for cancer prognosis using cellular folate vitamin receptor quantification
|
US20060239910A1
(en)
|
2005-04-22 |
2006-10-26 |
Morphotek Inc. |
Antibodies with immune effector activity and that internalize in folate receptor alpha-positive cells
|
EP1888639A1
(en)
|
2005-05-12 |
2008-02-20 |
Oncotherapy Science, Inc. |
Methods for damaging cells using effector function of anti-dsc2 antibody
|
AU2006249087B2
(en)
|
2005-05-20 |
2012-05-17 |
Lonza Biologics Plc |
High-level expression of recombinant antibody in a mammalian host cell
|
US20090285795A1
(en)
|
2005-05-24 |
2009-11-19 |
Villoo Morawala Patell |
Method for the Production of a Monoclonal Antibody to CD20 for the Treatment of B-Cell Lymphoma
|
EP1904183B1
(en)
|
2005-07-05 |
2014-10-15 |
Purdue Research Foundation |
Pharmaceutical composition for the treatment of osteoarthritis
|
US7521195B1
(en)
|
2005-07-21 |
2009-04-21 |
Celera Corporation |
Lung disease targets and uses thereof
|
WO2007022416A2
(en)
|
2005-08-18 |
2007-02-22 |
Ramot At Tel Aviv University Ltd. |
Single chain antibodies against beta-amyloid peptide
|
JP5376948B2
(ja)
|
2005-09-13 |
2013-12-25 |
ナショナル リサーチ カウンシル オブ カナダ |
腫瘍細胞活性を調節する方法及び組成物
|
AU2006304605A1
(en)
|
2005-10-17 |
2007-04-26 |
Institute For Systems Biology |
Tissue-and serum-derived glycoproteins and methods of their use
|
EP1790664A1
(en)
|
2005-11-24 |
2007-05-30 |
Ganymed Pharmaceuticals AG |
Monoclonal antibodies against claudin-18 for treatment of cancer
|
ES2526079T3
(es)
|
2005-12-20 |
2015-01-05 |
Sbi Biotech Co., Ltd. |
Anticuerpo anti-ILT7
|
WO2007143561A1
(en)
|
2006-06-01 |
2007-12-13 |
Mayo Foundation For Medical Education And Research |
Immunity to folate receptors
|
JP5564249B2
(ja)
|
2006-06-23 |
2014-07-30 |
アレシア・バイオセラピューティクス・インコーポレーテッド |
癌に関与するポリヌクレオチド配列およびポリペプチド配列
|
US7910702B2
(en)
|
2006-07-28 |
2011-03-22 |
The Governors Of The University Of Alberta |
Recombinant antibodies to sclerotinia antigens
|
JP5244103B2
(ja)
|
2006-08-09 |
2013-07-24 |
ホームステッド クリニカル コーポレイション |
器官特異的蛋白質およびその使用方法
|
US20090182955A1
(en)
|
2006-09-08 |
2009-07-16 |
Rao Cherukuri |
Application configuration across client devices of a local system
|
EP1900752A1
(en)
*
|
2006-09-15 |
2008-03-19 |
DOMPE' pha.r.ma s.p.a. |
Human anti-folate receptor alpha antibodies and antibody fragments for the radioimmunotherapy of ovarian carcinoma
|
MX2009003738A
(es)
|
2006-10-12 |
2009-07-17 |
Forerunner Pharma Res Co Ltd |
Diagnóstico y tratamiento de cáncer usando anticuerpo anti-ereg.
|
WO2008072723A1
(ja)
|
2006-12-14 |
2008-06-19 |
Forerunner Pharma Research Co., Ltd. |
抗Claudin3モノクローナル抗体およびそれを用いる癌の治療および診断
|
MX2009006659A
(es)
|
2006-12-20 |
2009-10-12 |
Mmr Information Systems Inc |
Anticuerpos y metodos de elaboracion y uso.
|
US20080227704A1
(en)
|
2006-12-21 |
2008-09-18 |
Kamens Joanne S |
CXCL13 binding proteins
|
US7691980B2
(en)
|
2007-01-09 |
2010-04-06 |
Bio-Rad Laboratories, Inc. |
Enhanced capacity and purification of antibodies by mixed mode chromatography in the presence of aqueous-soluble nonionic organic polymers
|
WO2008101231A2
(en)
|
2007-02-16 |
2008-08-21 |
Endocyte, Inc. |
Methods and compositions for treating and diagnosing kidney disease
|
EP2129402A2
(en)
|
2007-02-16 |
2009-12-09 |
KTB Tumorforschungsgesellschaft mbH |
Receptor and antigen targeted prodrug
|
WO2008145136A1
(en)
|
2007-05-30 |
2008-12-04 |
Aarhus Universitet |
Stat3 inactivation by inhibition of the folate receptor pathway
|
RU2523909C2
(ru)
|
2007-06-25 |
2014-07-27 |
Эндосайт, Инк. |
Конъюгаты, содержащие гидрофильные спейсеры линкеров
|
CN101139613B
(zh)
|
2007-08-01 |
2011-06-08 |
姜荣锡 |
抗肿瘤二元多肽及其应用与制备方法
|
PL2227549T3
(pl)
|
2007-12-21 |
2015-12-31 |
Novartis Ag |
System selekcji do hodowli komórek eukariotycznych oparty na genie związanego z błoną receptora folianowego
|
SG187457A1
(en)
|
2008-01-11 |
2013-02-28 |
Univ Tokyo |
Anti-cldn6 antibody
|
WO2009092010A1
(en)
|
2008-01-18 |
2009-07-23 |
Gagnon Peter S |
Enhanced purification of phosphorylated and non-phosphorylated biomolecules by apatite chromatography
|
JP5470817B2
(ja)
|
2008-03-10 |
2014-04-16 |
日産自動車株式会社 |
電池用電極およびこれを用いた電池、並びにその製造方法
|
CA2722190A1
(en)
|
2008-04-21 |
2009-10-29 |
Swapsol Corp. |
Hydrogen sulfide conversion to hydrogen
|
WO2009132081A2
(en)
|
2008-04-24 |
2009-10-29 |
The Research Foundation Of State University Of New York |
Monoclonal antibody-based targeting of folate receptors
|
RU2487877C2
(ru)
|
2008-04-30 |
2013-07-20 |
Иммьюноджен, Инк. |
Высокоэффективные конъюгаты и гидрофильные сшивающие агенты (линкеры)
|
JP5769616B2
(ja)
|
2008-04-30 |
2015-08-26 |
イミュノジェン・インコーポレーテッド |
クロスリンカーおよびそれらの使用
|
US8383351B2
(en)
|
2008-06-11 |
2013-02-26 |
Oxford Brookes University |
Antibody to inhibin/ activin β-B subunit
|
US20100069298A1
(en)
*
|
2008-09-16 |
2010-03-18 |
Robert Penny |
Methods for Detecting Overexpression of SPARC and Therapeutic and Diagnostic Methods Relating to Same
|
NZ592255A
(en)
|
2008-09-17 |
2013-07-26 |
Endocyte Inc |
Folate receptor binding conjugates of antifolates
|
US20100092470A1
(en)
|
2008-09-22 |
2010-04-15 |
Icb International, Inc. |
Antibodies, analogs and uses thereof
|
CN101440130B
(zh)
|
2008-11-21 |
2011-07-27 |
中国人民解放军第四军医大学 |
一种抗人IL-13Rα2单克隆抗体的重链和轻链的可变区
|
ES2557914T3
(es)
|
2009-03-24 |
2016-01-29 |
Biocept, Inc. |
Dispositivos y métodos de captura y análisis de células
|
EP2462161B1
(en)
*
|
2009-08-06 |
2017-03-08 |
Immunas Pharma, Inc. |
Antibodies that specifically bind to a beta oligomers and use thereof
|
WO2011100398A1
(en)
|
2010-02-10 |
2011-08-18 |
Immunogen, Inc. |
Cd20 antibodies and uses thereof
|
TWI504408B
(zh)
|
2010-02-24 |
2015-10-21 |
Immunogen Inc |
葉酸受體1抗體類和免疫共軛物類及彼等之用途
|
RU2013122843A
(ru)
*
|
2010-10-20 |
2014-11-27 |
Морфотек, Инк. |
Гликоформы антитела против фолатного рецептора альфа
|
CA2816991C
(en)
*
|
2010-11-05 |
2020-06-09 |
Morphotek Inc. |
Folate receptor alpha as a diagnostic and prognostic marker for folate receptor alpha-expressing cancers
|
EA201991268A3
(ru)
|
2011-03-29 |
2020-01-31 |
Иммуноджен, Инк. |
Получение конъюгатов "майтансиноид-антитело" одностадийным способом
|
US20120259100A1
(en)
|
2011-03-29 |
2012-10-11 |
Immunogen, Inc. |
Process for manufacturing conjugates of improved homogeneity
|
KR20200039843A
(ko)
|
2011-04-01 |
2020-04-16 |
이뮤노젠 아이엔씨 |
Folr1 암 치료의 효능을 증가시키기 위한 방법
|
WO2012138749A1
(en)
|
2011-04-04 |
2012-10-11 |
Immunogen, Inc. |
Methods for decreasing ocular toxicity of antibody drug conjugates
|
RS56985B1
(sr)
|
2011-07-15 |
2018-05-31 |
Eisai R&D Man Co Ltd |
Antitela protiv alfa receptora folata i njihove upotrebe
|
KR20150046316A
(ko)
|
2012-08-31 |
2015-04-29 |
이뮤노젠 아이엔씨 |
엽산 수용체 1의 검출을 위한 진단성 검정 및 키트
|
EP2930240B1
(en)
|
2012-12-07 |
2018-08-01 |
Kyowa Hakko Kirin Co., Ltd. |
Anti-folr1 antibody
|
JP6136279B2
(ja)
|
2013-01-15 |
2017-05-31 |
株式会社ジェイテクト |
転がり軸受装置
|
TWI503850B
(zh)
|
2013-03-22 |
2015-10-11 |
Polytronics Technology Corp |
過電流保護元件
|
EP2997044A4
(en)
|
2013-05-14 |
2017-03-22 |
ImmunoGen, Inc. |
Anti-folr1 immunoconjugate dosing regimens
|
EP3925980A1
(en)
|
2013-08-30 |
2021-12-22 |
ImmunoGen, Inc. |
Antibodies and assays for detection of folate receptor 1
|
TWI510996B
(zh)
|
2013-10-03 |
2015-12-01 |
Acer Inc |
控制觸控面板的方法以及使用該方法的可攜式電腦
|
DK3055332T3
(da)
|
2013-10-08 |
2019-12-09 |
Immunogen Inc |
Anti-folr1-immunkonjugat-doseringsregimer
|
WO2015149018A1
(en)
|
2014-03-28 |
2015-10-01 |
Immunogen, Inc. |
Anti-folr1 immunoconjugate dosing regimens
|
KR20180053319A
(ko)
|
2015-09-17 |
2018-05-21 |
이뮤노젠 아이엔씨 |
항-folr1 면역접합체를 포함하는 치료제 조합
|
US9816280B1
(en)
|
2016-11-02 |
2017-11-14 |
Matthew Reitnauer |
Portable floor
|